These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38823278)

  • 1. Pro-cognitive effects of dual tacrine derivatives acting as cholinesterase inhibitors and NMDA receptor antagonists.
    Chvojkova M; Kolar D; Kovacova K; Cejkova L; Misiachna A; Hakenova K; Gorecki L; Horak M; Korabecny J; Soukup O; Vales K
    Biomed Pharmacother; 2024 Jul; 176():116821. PubMed ID: 38823278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of dually-acting acetylcholinesterase inhibitors derived from tacrine on N-methyl-d-Aspartate receptors.
    Gorecki L; Misiachna A; Damborsky J; Dolezal R; Korabecny J; Cejkova L; Hakenova K; Chvojkova M; Karasova JZ; Prchal L; Novak M; Kolcheva M; Kortus S; Vales K; Horak M; Soukup O
    Eur J Med Chem; 2021 Jul; 219():113434. PubMed ID: 33892271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMDA-but not AMPA-receptor antagonists augment scopolamine-induced spatial cognitive deficit of rats in a radial maze task.
    Li HB; Matsumoto K; Tohda M; Yamamoto M; Watanabe H
    Brain Res; 1996 Jul; 725(2):268-71. PubMed ID: 8836535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dual-acting AChE inhibitor and H3 receptor antagonist UW-MD-72 reverses amnesia induced by scopolamine or dizocilpine in passive avoidance paradigm in rats.
    Sadek B; Khan N; Darras FH; Pockes S; Decker M
    Physiol Behav; 2016 Oct; 165():383-91. PubMed ID: 27568232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flumazenil and tacrine increase the effectiveness of ondansetron on scopolamine-induced impairment of spatial learning in rats.
    Diez-Ariza M; Redondo C; García-Alloza M; Lasheras B; Del Río J; Ramírez MJ
    Psychopharmacology (Berl); 2003 Aug; 169(1):35-41. PubMed ID: 12845416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of Memantine and 6-Chlorotacrine as Novel Multi-Target Compound against Alzheimer's Disease.
    Kaniakova M; Nepovimova E; Kleteckova L; Skrenkova K; Holubova K; Chrienova Z; Hepnarova V; Kucera T; Kobrlova T; Vales K; Korabecny J; Soukup O; Horak M
    Curr Alzheimer Res; 2019; 16(9):821-833. PubMed ID: 30819076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of novel tacrine-related cholinesterase inhibitors in the reversal of 3-quinuclidinyl benzilate-induced cognitive deficit in rats--Is there a potential for Alzheimer's disease treatment?
    Misik J; Korabecny J; Nepovimova E; Kracmarova A; Kassa J
    Neurosci Lett; 2016 Jan; 612():261-268. PubMed ID: 26708634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory avoidance memory deficit induced by scopolamine: Interaction of cholinergic and glutamatergic systems in the ventral tegmental area.
    Mahmoodi G; Ahmadi S; Pourmotabbed A; Oryan S; Zarrindast MR
    Neurobiol Learn Mem; 2010 Jul; 94(1):83-90. PubMed ID: 20403448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice.
    Dall'Igna OP; Da Silva AL; Dietrich MO; Hoffmann A; de Oliveira RV; Souza DO; Lara DR
    Psychopharmacology (Berl); 2003 Mar; 166(3):258-63. PubMed ID: 12589526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrine(10)-hupyridone, a dual-binding acetylcholinesterase inhibitor, potently attenuates scopolamine-induced impairments of cognition in mice.
    Chen H; Xiang S; Huang L; Lin J; Hu S; Mak SH; Wang C; Wang Q; Cui W; Han Y
    Metab Brain Dis; 2018 Aug; 33(4):1131-1139. PubMed ID: 29564727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation into the in vivo effects of five novel tacrine/ferulic acid and beta-carboline derivatives on scopolamine-induced cognitive impairment in rats using radial maze paradigm.
    Fleck C; Appenroth D; Fang L; Schott Y; Lehmann J; Decker M
    Arzneimittelforschung; 2010; 60(6):299-306. PubMed ID: 20648918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice.
    Csernansky JG; Martin M; Shah R; Bertchume A; Colvin J; Dong H
    Neuropsychopharmacology; 2005 Dec; 30(12):2135-43. PubMed ID: 15956997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Huperzine A, a novel promising acetylcholinesterase inhibitor.
    Cheng DH; Ren H; Tang XC
    Neuroreport; 1996 Dec; 8(1):97-101. PubMed ID: 9051760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The memory-ameliorating effects of Artemisia princeps var. orientalis against cholinergic dysfunction in mice.
    Liu X; Kim DH; Kim JM; Park SJ; Cai M; Jang DS; Ryu JH
    Am J Chin Med; 2012; 40(5):993-1005. PubMed ID: 22928830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of NMDA receptors in the beneficial effects of pioglitazone on scopolamine-induced memory impairment in mice.
    Almasi-Nasrabadi M; Javadi-Paydar M; Mahdavian S; Babaei R; Sharifian M; Norouzi A; Dehpour AR
    Behav Brain Res; 2012 May; 231(1):138-45. PubMed ID: 22440233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel dimeric acetylcholinesterase inhibitor bis7-tacrine, but not donepezil, prevents glutamate-induced neuronal apoptosis by blocking N-methyl-D-aspartate receptors.
    Li W; Pi R; Chan HH; Fu H; Lee NT; Tsang HW; Pu Y; Chang DC; Li C; Luo J; Xiong K; Li Z; Xue H; Carlier PR; Pang Y; Tsim KW; Li M; Han Y
    J Biol Chem; 2005 May; 280(18):18179-88. PubMed ID: 15710623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMDA antagonists potentiate scopolamine-induced amnesic effect.
    Li HB; Matsumoto K; Tohda M; Yamamoto M; Watanabe H
    Behav Brain Res; 1997 Feb; 83(1-2):225-8. PubMed ID: 9062690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of scopolamine-induced deficits in navigational memory performance in rats by bis(7)-tacrine, a novel dimeric AChE inhibitor.
    Wang H; Carlier PR; Ho WL; Lee NT; Pang YP; Han YF
    Zhongguo Yao Li Xue Bao; 1999 Mar; 20(3):211-7. PubMed ID: 10452094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dual-acting H3 receptor antagonist and AChE inhibitor UW-MD-71 dose-dependently enhances memory retrieval and reverses dizocilpine-induced memory impairment in rats.
    Khan N; Saad A; Nurulain SM; Darras FH; Decker M; Sadek B
    Behav Brain Res; 2016 Jan; 297():155-64. PubMed ID: 26467607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase - Design, synthesis and biological evaluation.
    Remya C; Dileep KV; Koti Reddy E; Mantosh K; Lakshmi K; Sarah Jacob R; Sajith AM; Jayadevi Variyar E; Anwar S; Zhang KYJ; Sadasivan C; Omkumar RV
    Comput Struct Biotechnol J; 2021; 19():4517-4537. PubMed ID: 34471497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.